3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
9
Colorectal Neoplasms
7
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Colonic Neoplasms
5
Rectal Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Pancreatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Brain Neoplasms
3
Urogenital Neoplasms
2
Neoplastic Syndromes, Hereditary
2
Neoplasms, Unknown Primary
2
Neoplasm Metastasis
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia, Eosinophilic, Acute
2
Leukemia, Basophilic, Acute
2
Leukemia
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Hematologic Neoplasms
2
Glioma
2
Carcinoma, Intraductal, Noninfiltrating
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Tuberous Sclerosis
1
Thyroid Neoplasms
1
Spinal Cord Neoplasms
1
Interventions
Surveys and Questionnaires
114
Exercise
103
Blood Specimen Collection
99
Radiotherapy
66
Gemcitabine
64
Bevacizumab
57
Standard of Care
56
Cisplatin
55
Cyclophosphamide
51
Capecitabine
50
Carboplatin
49
Docetaxel
47
pembrolizumab
46
Dexamethasone
46
Paclitaxel
45
Interviews as Topic
43
Oxaliplatin
40
Magnetic Resonance Spectroscopy
39
Fluorouracil
37
Methods
36
Irinotecan
36
Therapeutics
33
Drug Therapy
32
Radiosurgery
31
Nivolumab
30
Erlotinib Hydrochloride
27
Educational Status
26
Everolimus
24
Leucovorin
23
Control Groups
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms
×
Genetic Testing
×
Clear all
NCT06008392
2026-04-07
INTERCEPTioN
Mayo Clinic
Recruiting
500 enrolled